Feb 21 |
Bausch + Lomb Corporation 2023 Q4 - Results - Earnings Call Presentation
|
Feb 21 |
Bausch & Lomb Corp (BLCO) Reports Robust Revenue Growth Amidst Net Loss in Q4 and Full-Year 2023
|
Feb 21 |
Emergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEO
|
Feb 21 |
Bausch + Lomb Non-GAAP EPS of $0.24 beats by $0.07, revenue of $1.17B beats by $70M
|
Feb 21 |
Bausch + Lomb Announces Fourth-Quarter and Full-Year 2023 Results and Provides 2024 Guidance
|
Feb 21 |
Earnings Scheduled For February 21, 2024
|
Feb 20 |
Bausch + Lomb Q4 2023 Earnings Preview
|
Feb 14 |
Eminence Capital adds Sea, AMD stakes; exits Peloton, Bausch + Lomb in Q4
|
Feb 5 |
Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2023 Financial Results on February 21
|
Jan 31 |
Hovering Around 52-Week Low, Bausch + Lomb May Be Poised For A Rebound
|